Buhr, Wilm,Burckhardt, Susanna,Durrenberger, Franz,Funk, Felix,Geisser, Peter Otto,Corden, Vincent Anthony,Courtney, Stephen Martin,Davenport, Tara,Slack, Mark,Ridgill, Mark Peter,Yarnold, Christopher
申请号:
AU2012217021
公开号:
AU2012217021A1
申请日:
2012.02.16
申请国别(地区):
AU
年份:
2013
代理人:
摘要:
The present invention relates to novel hepcidin antagonists of formula (I), pharmaceutical compositions comprising them and the use thereof as medicaments for the use in the treatment of iron metabolism disorders, such as, in particular, iron deficiency diseases and anaemias, in particular anaemias in connection with chronic inflammatory diseases (ACD: anaemia of chronic disease and Al; anaemia of inflammation).